Although CD44 and CD133 have been used to enrich CSCs from human breast cancer [2, 24], colon cancer [25–27], and liver cancer [28, 29], CD44 was detected on the mouse breast EMT6, colon CT26, and liver Hepa1-6 CCs. Here, CD44 is linked to breast cancer.